0001342792 false --07-31 2022 Q1 26106 12200 923502 910877 9 2015-07-31 0001342792 2021-08-01 2021-10-31 0001342792 2021-12-10 0001342792 2021-10-31 0001342792 2021-07-31 0001342792 us-gaap:SeriesAPreferredStockMember 2021-10-31 0001342792 us-gaap:SeriesAPreferredStockMember 2021-07-31 0001342792 us-gaap:SeriesBPreferredStockMember 2021-10-31 0001342792 us-gaap:SeriesBPreferredStockMember 2021-07-31 0001342792 2020-08-01 2020-10-31 0001342792 WWSG:SerieAPreferredStockMember 2020-07-31 0001342792 WWSG:SerieBPreferredStockMember 2020-07-31 0001342792 us-gaap:CommonStockMember 2020-07-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2020-07-31 0001342792 us-gaap:RetainedEarningsMember 2020-07-31 0001342792 2020-07-31 0001342792 WWSG:SerieAPreferredStockMember 2020-08-01 2020-10-31 0001342792 WWSG:SerieBPreferredStockMember 2020-08-01 2020-10-31 0001342792 us-gaap:CommonStockMember 2020-08-01 2020-10-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2020-08-01 2020-10-31 0001342792 us-gaap:RetainedEarningsMember 2020-08-01 2020-10-31 0001342792 WWSG:SerieAPreferredStockMember 2020-10-31 0001342792 WWSG:SerieBPreferredStockMember 2020-10-31 0001342792 us-gaap:CommonStockMember 2020-10-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2020-10-31 0001342792 us-gaap:RetainedEarningsMember 2020-10-31 0001342792 2020-10-31 0001342792 WWSG:SerieAPreferredStockMember 2021-07-31 0001342792 WWSG:SerieBPreferredStockMember 2021-07-31 0001342792 us-gaap:CommonStockMember 2021-07-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2021-07-31 0001342792 us-gaap:RetainedEarningsMember 2021-07-31 0001342792 WWSG:SerieAPreferredStockMember 2021-08-01 2021-10-31 0001342792 WWSG:SerieBPreferredStockMember 2021-08-01 2021-10-31 0001342792 us-gaap:CommonStockMember 2021-08-01 2021-10-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2021-08-01 2021-10-31 0001342792 us-gaap:RetainedEarningsMember 2021-08-01 2021-10-31 0001342792 WWSG:SerieAPreferredStockMember 2021-10-31 0001342792 WWSG:SerieBPreferredStockMember 2021-10-31 0001342792 us-gaap:CommonStockMember 2021-10-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2021-10-31 0001342792 us-gaap:RetainedEarningsMember 2021-10-31 0001342792 us-gaap:ConvertiblePreferredStockMember 2021-08-01 2021-10-31 0001342792 us-gaap:ConvertiblePreferredStockMember 2020-08-01 2020-10-31 0001342792 us-gaap:ConvertibleDebtMember 2021-08-01 2021-10-31 0001342792 us-gaap:ConvertibleDebtMember 2020-08-01 2020-10-31 0001342792 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2021-10-31 0001342792 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2021-10-31 0001342792 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2021-10-31 0001342792 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2021-07-31 0001342792 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2021-07-31 0001342792 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2021-07-31 0001342792 WWSG:CeoAndCfoMember 2021-08-01 2021-10-31 0001342792 WWSG:CeoAndCfoMember 2021-10-31 0001342792 WWSG:PayableToShareholderMember 2021-10-31 0001342792 WWSG:PayableToShareholderMember 2021-07-31 0001342792 WWSG:ConvertibleNote1Member 2021-07-31 0001342792 WWSG:ConvertibleNote1Member 2021-08-01 2021-10-31 0001342792 WWSG:ConvertibleNote2Member 2021-07-31 0001342792 WWSG:ConvertibleNote2Member 2021-08-01 2021-10-31 0001342792 WWSG:ConvertibleNote3Member 2021-10-31 0001342792 WWSG:ConvertibleNote3Member 2021-07-31 0001342792 WWSG:ConvertibleNote3Member 2021-08-01 2021-10-31 0001342792 WWSG:ConvertibleNote4Member 2021-10-31 0001342792 WWSG:ConvertibleNote4Member 2021-07-31 0001342792 WWSG:ConvertibleNote4Member 2021-08-01 2021-10-31 0001342792 WWSG:ConvertibleNote5Member 2021-10-31 0001342792 WWSG:ConvertibleNote5Member 2021-07-31 0001342792 WWSG:ConvertibleNote5Member 2021-08-01 2021-10-31 0001342792 WWSG:FitwellMember 2021-09-01 2021-09-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~Washington~~WASHINGTON, D.C. ~~2054~~20549

FORM 10-Q

(Mark One)

ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended October 31, 2021

or

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from _____ to _____

~~For~~Commission ~~the~~File ~~quarterly~~Number: ~~period ended April 30, 2015~~000-52362

☐WORLDWIDE STRATEGIES ~~TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934~~INC.

~~For~~(Exact ~~the~~Name ~~transition~~of ~~period~~Registrant ~~from~~as ~~________________~~Specified in toits ~~_______________~~Charter)

Commission file number: 000-52362

Nevada

41-0946897

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

Worldwide Strategies Incorporated

1961 NW 150 AVENUE, SUITE 205

PEMBROKE PINES, FL

33028

(Address of principal executive offices)

(Zip code)

~~(Exact~~1 ~~name~~844 of500 ~~registrant~~9974 as(Registrant’s ~~specified~~telephone innumber, ~~its~~including ~~charter~~area code)

Nevada	41-0946897
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
3801 East Florida Avenue, Suite 400, Denver, Colorado	80210
(Address of principal executive offices)	(Zip Code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (~~303~~§232.405 of this chapter) ~~991-5887~~during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

~~(Registrant's~~Indicate ~~telephone~~by ~~number~~check mark whether the registrant is a large accelerated filer, ~~including~~an ~~area~~accelerated ~~code)~~filer, a non-accelerated filer, a smaller reporting company or, an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company”, in Rule 12b-2 of the Exchange Act.

~~Not~~Large ~~applicable~~accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐

~~(Former~~If ~~name,~~an ~~former~~emerging ~~address~~growth ~~and~~company, indicate ~~former~~by ~~fiscal~~check ~~year,~~mark if the ~~changed~~registrant has ~~since~~elected ~~last~~not ~~report~~to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant ~~(1)~~is ~~has~~a ~~filed~~shell ~~all~~company ~~reports~~(as ~~required~~defined toin beRule ~~filed~~12b-2 ~~by Section 13 or 15(d)~~ of the ~~Securities~~ Exchange Act ~~of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports~~),. ~~and~~Yes ~~(2)~~☒ No ~~has been subject to such filing requirements for the past 90 days.~~☐

~~Yes~~Securities ~~ý No~~registered ☐pursuant to Section 12(b) of the Act: None

~~Indicate~~Securities byregistered ~~check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted~~ pursuant to ~~Rule~~Section ~~405 of Regulation S-T during the preceding~~ 12 ~~months~~ (org) ~~for~~of ~~such shorter period that~~ the ~~registrant was required to submit and post such files). Yes ý No ☐~~Act:

See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Title of each class	Trading Symbol (s)	Name of each exchange on which registered

Common Stock, $0.001 par value	WWSG	OTC

~~Large~~As ~~accelerated~~of ~~filer~~December ☐10, ~~Accelerated~~2021, ~~filer~~there were ☐19,830,679 shares ~~Non-accelerated~~of ~~filer~~the ☐registrant’s ~~Smaller~~common ~~reporting~~stock, ~~company~~$0.001 ýpar value, outstanding.

~~Indicate~~TABLE byOF ~~check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ý No ☐~~CONTENTS

Indicate the number of shares outstanding of each of the registrant's classes of common equity, as of the latest practicable date: 19,830,672 on May 18, 2015

	Part I. Financial Information	Page No.

Item 1.	Financial Statements of Worldwide Strategies, Inc.	1

	Condensed Balance Sheets - October 31, 2021 (Unaudited) and July 31, 2021	1

	Condensed Statements of Operations - Three Months Ended October 31, 2021 and 2020 (Unaudited)	2

	Condensed Statement of Changes in Stockholders’ Deficit - Three Months Ended October 31, 2021 and 2020 (Unaudited)	3

	Condensed Statements of Cash Flows - Three Months Ended October 31, 2021 and 2020 (Unaudited)	4

	Notes to Financial Statements - Three Months Ended October 31, 2021 and 2020 (Unaudited)	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	10

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	11

Item 4.	Controls and Procedures	11

	Part II. Other Information

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	12

Item 5.	Other Information	12

Item 6.	Exhibits	12

SIGNATURES		13

~~WORLDWIDE STRATEGIES INCORPORATED~~i

~~FORM~~PART ~~10-Q~~I. FINANCIAL INFORMATION

~~FOR~~Item ~~THE~~1. ~~FISCAL~~Financial ~~QUARTER~~Statements ~~ENDED~~of Worldwide Strategies, Inc.

~~APRIL~~Worldwide 30Strategies, ~~2015~~Inc.

~~INDEX~~Condensed Balance Sheets

			Page
PART I. FINANCIAL INFORMATION
Item 1.		Financial Statements
		Consolidated Condensed Balance Sheets (unaudited)	2
		Consolidated Condensed Statements of Operations (unaudited)	3
		Consolidated Condensed Statement of Changes in Shareholders' Deficit (unaudited)	4
		Consolidated Condensed Statements of Cash Flows (unaudited)	5
		Notes to Consolidated Condensed Financial Statements (unaudited)	6
Item 2.		Management's Discussion and Analysis of Financial Condition and Results of Operations	17
Item 3.		Quantitative and Qualitative Disclosures about Market Risk	20
Item 4.		Controls and Procedures	20
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings		21
Item 1A.	Risk Factors		21
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		21
Item 3.	Defaults Upon Senior Securities		21
Item 4.	Mine Safety Disclosures		21
Item 5.	Other Information		21
Item 6.	Exhibits		22
SIGNATURES			23

October 31, 2021 and July 31, 2021


	October 31, 2021 (Unaudited)			July 31, 2021 (Audited)
Assets
Current Assets:
Cash	$	–		$	–
Total assets	$	–		$	–

Liabilities and Stockholders' Deficit
Current Liabilities:
Accounts payable	$	42,967		$	42,967
Accrued liabilities		388,129			375,504
Convertible notes payable, in default		452,406			452,406
Convertible notes payable, related party - in default		40,000			40,000
Total current liabilities		923,502			910,877

Long term notes payable - related party		28,058			14,577

Total Liabilities		951,560			925,454

Stockholders' deficit:
Preferred Stock; $.001 par value; 25,000,000 shares authorized		–			–
Series A, 5,000,000 shares issued and outstanding		5,000			5,000
Series B, 270,000 shares issued and outstanding		270			270
Common stock, $.001 par value, 975,000,000 shares authorized 19,830,679 shares issued and outstanding, respectively		19,831			19,831
Additional paid-in capital		14,497,273			14,497,273
Accumulated deficit		(15,473,934	)		(15,447,828	)
Total Stockholders' Deficit		(951,560	)		(925,454	)
Total Liabilities and Stockholders' Deficit	$	–		$	–

See accompanying notes to condensed financial statements.

~~WORLDWIDE~~Worldwide ~~STRATEGIES~~Strategies, ~~INCORPORATED~~Inc.

~~Consolidated~~ Condensed Statements ~~Balance~~of ~~Sheets~~Operations

~~(unaudited)~~For the three months ended October 31, 2021 and 2020

		April 30,				July 31,
		2015				2014
Assets
Current Assets:
Cash	$		5,809		$		2,139
Total current assets			5,809				2,139
Deposits			150				150
Total assets	$		5,959		$		2,289
Liabilities and Shareholders' Deficit
Current Liabilities:
Accounts and notes payable:
Accounts payable	$		73,089		$		84,372
Accounts payable, related party			3,900				3,900
Accrued liabilities			68,816				42,902
Accrued liabilities, related party			28,659				18,041
Convertible notes payable, related party, net of unamortized discount
of $517 and 1,018, respectively			76,407				73,833
Convertible notes payable, related party, in default			65,000				65,000
Convertible notes payable, net of unamortized discount
of $11,812 and $1,341, respectively			279,725				164,696
Convertible notes payable, in default			2,000				2,000
Total current liabilities			597,596				454,744
Shareholders' deficit:
Preferred stock, $.001 par value; 25,000,000 shares authorized,
1,491,743 shares issued and outstanding			1,492				1,492
Common stock, $.001 par value, 33,333,333 shares authorized
19,830,672 shares issued and outstanding			19,831				19,831
Additional paid-in capital			7,774,448				7,692,896
Accumulated deficit			(8,387,408	)			(8,166,674	)
Total shareholders' deficit			(591,637	)			(452,455	)
Total liabilities and shareholders' deficit	$		5,959		$		2,289

(Unaudited)

See accompanying notes to conolidated condensed financial statements


	Three Months Ended October 31,
	2021			2020
Operating expenses:
Other general and administrative expenses	$	13,885		$	300
Total operating expenses		13,885			300
Loss from operations		(13,885	)		(300	)
Other expense:
Interest expense		(12,221	)		(11,900	)
Loss before income taxes		(26,106	)		(12,200	)
Income tax provision		–			–
Net loss	$	(26,106	)	$	(12,200	)

Basic and diluted loss per share	$	(0.00	)	$	(0.00	)

Basic and diluted weighted average common shares outstanding		19,830,679			19,830,679

See accompanying notes to condensed financial statements.

~~WORLDWIDE~~Worldwide ~~STRATEGIES~~Strategies, ~~INCORPORATED~~Inc.

~~Consolidated~~ Condensed Statements of ~~Operations~~Changes in Stockholders’ Deficit

~~(unaudited)~~For the three months ended October 31, 2021 and 2020

		Nine Months Ended								Three Months Ended
		April 30,								April 30,
		2015				2014				2015				2014
Sales	$		—		$		—		$		—		$		—
Cost of sales			—				—				—				—
			—				—				—				—
Operating expenses:
Professional and consulting fees			146,115				30,391				76,736				3,050
Travel			3,251				601				1,147				—
Insurance			9,600				—				9,600				—
Other general and administrative expenses			13,014				4,073				11,463				966
Total operating expenses			171,980				35,065				98,946				4,016
Loss from operations			(171,980	)			(35,065	)			(98,946	)			(4,016	)
Other expense:
Interest expense			(48,754	)			(145,810	)			(20,959	)			(25,203	)
Loss before income taxes			(220,734	)			(180,875	)			(119,905	)			(29,219	)
Income tax provision			—				—				—				—
Net loss	$		(220,734	)	$		(180,875	)	$		(119,905	)	$		(29,219	)
Basic and diluted loss per share	$		(0.01	)	$		(0.01	)	$		(0.01	)	$		(0.00	)
Basic and diluted weighted average
common shares outstanding			19,830,672				19,557,290				19,830,672				19,702,582

(Unaudited)

See accompanying notes to conolidated condensed financial statements


	Preferred Stock							Common Stock
		Series A			Series B								Additional
		Shares		Par Value	Shares		Par Value		Shares		Par Value		Paid-In Capital		Accumulated Deficit			Total


Balance July 31, 2020		1,491,743	$	1,492	270,000	$	270		19,830,679	$	19,831	$	13,185,185	$	(14,070,055	)	$	(863,277	)
Net Loss		–		–	–		–		–		–		–		(12,200	)		(12,200	)
Balance October 31, 2020		1,491,743	$	1,492	270,000	$	270		19,830,679	$	19,831	$	13,185,185	$	(14,082,255	)	$	(875,477	)

	Preferred Stock							Common Stock
		Series A			Series B								Additional
		Shares		Par Value	Shares		Par Value		Shares		Par Value		Paid-In Capital		Accumulated Deficit			Total
Balance at July 31, 2021		5,000,000	$	5,000	270,000	$	270		19,830,679	$	19,831	$	14,497,273	$	(15,447,828	)	$	(925,454	)
Net Loss		–		–	–		–		–		–		–		(26,106	)		(26,106	)
Balance October 31, 2021		5,000,000	$	5,000	270,000	$	270		19,830,679	$	19,831	$	14,497,273	$	(15,473,934	)	$	(951,560	)

See accompanying notes to condensed financial statements.

~~WORLDWIDE~~Worldwide Strategies, ~~STRATEGIES INCORPORATED~~Inc.

~~Consolidated~~ Condensed Statements ~~Statement~~ of ~~Changes~~Cash ~~in Shareholders' Deficit~~Flows

~~(unaudited)~~For the three months ended October 31, 2021 and 2020

														Common
	Three Months Ended October 31,
														Stock							Additional
	2021				2020
	Preferred Stock							Common Stock						Subscriptions			Stock				Paid-In			Accumulated
Cash flows from operating activities:
	Shares				Par Value			Shares			Par Value			Receivable			Payable				Capital			Deficit				Total
Net loss	$	(26,106	)		$	(12,200	)
Balance at July 31, 2013		1,491,743		$		1,492			18,859,005	$		18,860	$		—	$		36,000		$		7,575,567	$		(7,959,949	)	$		(328,030	)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued in exchange for
Stock Based Compensation		–				–
interest, related party		—				—			671,667			671			—			—				39,629			—				40,300
Accrued liabilities		12,625				11,900
Common stock authorized for Feb 2012
Net cash used in operating activities		(13,481	)			(300	)
but not issued until March 2014		—				—			300,000			300			—			(36,000	)			35,700							—
Cash flows from financing activities:
Beneficial conversion feature		—				—			—			—			—			—				42,000			—				42,000
Related party loans		13,481				300
Net loss for the year ended July 31, 2014		—				—			—			—			—			—				—			(206,725	)			(206,725	)
Net cash provided by financing activities		13,481				300
Balance at July 31, 2014		1,491,743		$		1,492			19,830,672	$		19,831	$		—	$		—		$		7,692,896	$		(8,166,674	)	$		(452,455	)
Net cash provided by investing activities		–				–
Options issued in exchange for
Net increase in cash		–				–
executive compensation		—				—			—			—			—			—				44,902			—				44,902
Cash, beginning of period		–				–
Options issued in exchange for
Cash, end of period	$	–			$	–
Professional Services		—				—			—			—			—			—				4,995							4,995
Supplemental disclosure of cash flow information:
Beneficial conversion feature		—				—			—			—			—			—				31,655			—				31,655
Cash paid for taxes	$	–			$	–
Net loss for the period ended Apr 30, 2015		—				—			—			—			—			—				—			(220,734	)			(220,734	)
Cash paid for interest	$	–			$	–
Balance at April 30, 2015		1,491,743		$		1,492			19,830,672	$		19,831	$		—	$		—		$		7,774,448	$		(8,387,408	)	$		(591,637	)

See accompanying notes to ~~conolidated~~ condensed financial statements.

~~WORLDWIDE~~Worldwide ~~STRATEGIES~~Strategies, ~~INCORPORATED~~Inc.

~~Consolidated~~NOTES ~~Condensed~~TO ~~Statements~~FINANCIAL ~~of Cash Flows~~STATEMENTS

~~(unaudited)~~FOR THE THREE MONTHS ENDED OCTOBER 31, 2021 and 2020

		For the Nine Months Ended
		April 30,
		2015				2014
Cash flows from operating activities:
Net loss	$		(220,734	)	$		(180,875	)
Adjustments to reconcile net loss to net cash
used in operating activities:
Amortization of beneficial conversion feature			22,009				84,599
Executive compensation paid with options			44,902				—
Stock issued for promissory note extension			—				40,300
Consulting expense paid with options			4,995				—
Changes in current assets and liabilities:
Accounts payable and accrued liablities			44,630				9,258
Accounts payable and accrued
liabilities, related party			10,618				9,830
Net cash used in operating activities			(93,580	)			(36,888	)
Cash flows from financing activities:
Proceeds from notes payable, related party			1,750				18,000
Proceeds from notes payable			95,500				28,000
Payment of notes payable			—				(4,000	)
Payment of notes payable, related party			—				—
Net cash provided by financing activities			97,250				42,000
Net change in cash			3,670				5,112
Cash, beginning of period			2,139				3,537
Cash, end of period	$		5,809		$		8,649
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Income taxes	$		—		$		—
Interest	$		—		$		—
Non-cash investing/financing activities
Conversion of accounts payable to note payable	$		30,000		$		—
Beneficial Conversion Feature - Debt	$		31,655		$		38,000
Common shares issued out of stock payable			—				36,000

See accompanying notes to conolidated condensed financial statements

WORLDWIDE STRATEGIES INCORPORATED

Notes to Consolidated Financial Statements

(Unaudited)

(Note 1) – Organization, ~~Basis~~and Basis of Presentation, ~~and Summary of Significant Accounting Policies~~

Organization and Basis of Presentation

Worldwide Strategies Incorporated (“WWSG” or the "“Company"”) was ~~originally~~ incorporated inunder the ~~state~~laws of the State of Nevada on April 6, 1998~~. On~~ ~~March~~and 1,ceased ~~2005,~~operations ~~Worldwide~~in ~~Business~~2015. ~~Solutions~~The Company ~~Incorporated~~fully ~~("WBSI")~~impaired ~~was~~all ~~incorporated~~assets insince the ~~State~~shutdown of ~~Colorado~~its operations in 2015. On ~~July~~May 87, ~~2005~~2019, the ~~Company~~eight ~~acquired~~judicial ~~all~~District ~~the~~Court ~~shares~~ of ~~WBSI~~Nevada appointed ~~for~~Small ~~76.8%~~Cap ofCompliance, ~~the~~LLC ~~Company's~~(“Custodian”) ~~outstanding~~as ~~stock. The~~custodian ~~acquisition~~for ofWorldwide ~~WBSI~~Strategies ~~has~~Incorporated., proper notice having been ~~accounted~~given ~~for~~to asthe aofficers ~~recapitalization~~and directors of ~~WBSI. Therefore~~Worldwide ~~the~~Strategies ~~historical~~Incorporated ~~information~~with ~~prior~~no toopposition. On July 10, 2019, the ~~date~~Company filed a Certificate of ~~recapitalization~~Reinstatement iswith the ~~financial~~state ~~information~~ of ~~WBSI~~Nevada.

~~Effective~~The ~~July~~accompanying ~~31,~~financial ~~2007~~statements are prepared on the basis of accounting principles generally accepted in the United States of America (“GAAP”) and have been prepared assuming the continuation of the Company ~~filed~~as a ~~Certificate~~going concern. The Company has not yet established an ongoing source of ~~Change~~revenues sufficient ~~Pursuant~~to cover its operating costs and is dependent on debt and equity financing to ~~NRS~~fund 78its operations.~~209,~~ ~~which~~Management ~~decreased~~of the ~~number~~Company is ofmaking ~~its~~efforts ~~authorized~~to ~~shares~~raise additional funding until a registration statement relating to an equity funding facility is in effect. While management of ~~common~~the ~~stock~~Company ~~from~~believes ~~100~~that it will be successful in its capital formation and planned operating activities,~~000,000~~ there can be no assurance that the Company will be able to ~~33,333,333~~raise additional equity capital or be successful in the development and ~~reduced~~commercialization of the ~~number~~products it develops or initiates collaboration agreements thereon. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of ~~common~~assets ~~shares~~or ~~issued~~the amounts and ~~outstanding~~classification of liabilities that may result from ~~17,768,607~~the possible inability of the Company to ~~5,923,106~~continue as a going concern.

~~All~~Note ~~shares~~2 ~~and~~– ~~per~~Summary ~~share~~of ~~amounts~~significant accounting ~~in these Consolidated Financial Statements and related notes have been retroactively adjusted to reflect the reverse stock split for all periods presented.~~policies

OnCash ~~July 31, 2007, the Company acquired 100% of the issued~~ and ~~outstanding~~Cash shares of Centric Rx, Inc., ("Centric") in exchange for 2,250,000 shares of the Company's common stock. As a result of the acquisition, Centric became a wholly owned subsidiary of the Company and the results of its operation have been included in the Company's consolidated financial statements since the date of acquisition.Equivalents

~~Interim~~The ~~financial~~Company ~~data~~doesn’t ~~presented~~maintain ~~herein~~any bank ~~are~~accounts ~~unaudited. The~~and ~~unaudited~~does ~~interim~~not ~~financial~~have ~~information~~any ~~presented~~cash ~~herein~~in ~~has~~hand. ~~been~~For ~~prepared~~day-to-day bybusiness activities, the Company independs ~~accordance~~upon ~~with~~ the ~~accounting~~directors’ ~~policies~~personal accounts. inFor ~~its~~purposes ~~audited~~of ~~financial~~reporting within the statements ~~for~~of cash flows, the ~~period~~Company ~~ended~~considers ~~July~~all ~~31,~~cash ~~2014~~on hand, ~~included~~cash inaccounts ~~its~~not ~~annual~~subject to ~~report~~withdrawal onrestrictions ~~Form~~or ~~10-K~~penalties, and ~~should~~all behighly ~~read~~liquid indebt ~~conjunction~~instruments purchased with ~~the~~a ~~notes~~maturity ~~thereto~~of three months or less to be cash and cash equivalents.

InUse ~~the opinion~~ of management, all adjustments (consisting only of normal recurring adjustments) which are necessary to provide a fair presentation of operating results for the interim period presented have been made. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the year.Estimates

~~Development~~The ~~Stage~~preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

InLoss ~~June~~per ~~2014,~~Common the FASB issued ASU No. 2014-10: Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements to improve financial reporting by reducing cost and complexity associated with the incremental reporting requirements of development stage entities. The changes eliminate the need for inception to date reporting and other disclosure requirements. The amendments are effective for annual reporting periods beginning after December 15, 2014. Early adoption is permitted. The Company has elected early adoption of these amendments.Share

~~Going~~Net ~~Concern~~loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. As a result, diluted loss per common share is the same as basic loss per common share for the three months ended October 31, 2021 and 2020. Excluded from the weighted average common shares outstanding amount is convertible preferred stock equivalent to 301,250,000 and convertible debt equivalent to 45,393,500 common shares as the effect of these on the computation of net loss per share would have been anti-dilutive.

The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States, which contemplate continuation of the Company as a going concern. However, the Company experienced net losses of $220,734, and $206,725 for the nine-month period ended April 30, 2015 and for the year ended July 31, 2014, respectively. In addition, the Company has incurred liabilities in excess of assets over the past year and, as of April 30, 2015, has an accumulated deficit of $8,387,408. These matters, among others, raise substantial doubt about its ability to continue as a going concern.5

InIncome view of the matters described above, recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company's ability to generate sufficient sales volume to cover its operating expenses and to raise sufficient capital to meet its payment obligations. Historically, management has been able to raise additional capital. During the nine-month period ended April 30, 2015 and the year ended July 31, 2014, the Company issued convertible promissory notes in exchange for $97,250 and $46,000, respectively.Taxes

The Company accounts for income taxes pursuant to FASB ASC Topic 740, Income Taxes. Under FASB ASC Topic 740, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.

The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws.

Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the reliability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.

Fair Value of Financial Instruments

On August 1, 2012, the Company adopted ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:

	☐	Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
	☐	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
	☐	Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.

The following tables represent our assets and liabilities by level measured at fair value on a recurring basis at October 31, 2021 and July 31, 2021:

Fair Value Measurements at October 31, 2021

Level 1

Level 2

Level 3

Description

Convertible Debt

–

492,406

–

Total Liabilities

–

492,406

–

Totals

–

492,406

–

Fair Value Measurements at July 31, 2021

Level 1

Level 2

Level 3

Description

Convertible Debt

–

492,406

–

Total Liabilities

–

492,406

–

Totals

–

492,406

–

Reclassifications

Certain reclassifications have been made to the prior year presentation to conform to the current year presentation.

Recent Accounting Pronouncements

The Company reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company.

~~WORLDWIDE~~Note ~~STRATEGIES~~3- Going ~~INCORPORATED~~Concern

~~Notes~~For the three months ended October 31, 2021 and 2020 we incurred net losses of approximately $26,000 and $12,000 respectively. As of October 31, 2021, we had no cash on hand and current liabilities of $0.9 million. As of July 31, 2021, we had no cash on hand and current liabilities of $0.9 million. These losses combined with our current liabilities cast significant doubt on the company’s ability to ~~Consolidated~~operate ~~Financial~~under ~~Statements~~the going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with loans from directors and/or private placement of common stock. The failure to achieve the necessary levels of profitability or obtaining additional funding would be detrimental to the Company.

~~(Unaudited)~~Note 4 – Related party transactions

The ~~consolidated~~Company’s ~~financial~~CFO ~~statements~~has provided dooffice ~~not~~space ~~include~~at ~~any~~no ~~adjustments~~cost ~~relating~~ to the ~~recoverability~~Company. Our CEO and ~~classification~~CFO incurred expenses on behalf of ~~recorded~~the ~~asset~~Company ~~amounts~~amounting to approximately $14,000 during orthe three months ending October 31, 2021. As of October 31, 2021 total amounts due to our CEO and ~~classification~~CFO ofare ~~liabilities~~approximately $28,000. These ~~that~~amounts ~~might~~are bedue ~~necessary~~on ~~should~~December 31, ~~the~~2022 ~~Company~~and bebear ~~unable~~interest toat ~~continue~~eight inpercent ~~existence~~per annum. These amounts are included within long term notes payable - related party on the accompanying condensed balance sheet.

~~Significant~~As ~~Accounting~~of ~~Policies~~October 31, 2021 and July 31, 2021, the Company had a convertible promissory note in the principal outstanding balance of $40,000, payable to a shareholder. Such note bears interest at nine percent per annum with a maturity date of July 31, 2015. The principal and accrued interest is convertible, at the option of the holder, into common shares at $.01 per share. This amount is included within convertible notes payable - related party on the accompanying condensed balance sheet.

~~Stock-based~~Note ~~Compensation. The~~5 ~~Company~~– ~~accounts~~Convertible for all stock-based payments to employees and non-employees under Accounting Standards Codification (ASC) 718 Stock Compensation, using the fair value based method. Under the fair value method, stock-based payments are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The cost of stock-based payments to non-employees that are fully vested and non-forfeitable at the grant date is measured and recognized at that date.Notes Payable

~~Loss~~The ~~per~~Company ~~common~~has ~~share. We~~convertible ~~report~~promissory notes ~~net~~that ~~loss~~in ~~per~~the ~~share~~aggregate ~~using~~result in a ~~dual~~principal ~~presentation~~outstanding balance of ~~basic~~$160,750 as ~~and~~of ~~diluted~~October ~~loss~~31, ~~per~~2021 ~~share. Diluted~~and ~~net~~July ~~loss~~31, ~~per~~2021, ~~share~~respectively. ~~utilizes~~Interest ~~the~~on ~~average~~these ~~market~~notes ~~price~~range ~~per~~from ~~share~~nine to ~~when~~ten ~~applying~~percent ~~the~~per ~~treasury~~annum ~~stock~~and ~~method~~such innotes ~~determining~~had ~~common~~maturity ~~stock~~dates ~~equivalents. As~~ of ~~April 30~~July 31, 2015. ~~there~~The ~~were~~principal ~~2,600,000~~and ~~vested~~accrued ~~common~~interest ~~stock~~is ~~options outstanding~~convertible, ~~which~~at ~~were excluded from~~ the ~~calculation~~option of ~~net~~the ~~loss~~holder, ~~per~~into ~~share-diluted~~common ~~because~~shares ~~they~~at ~~were~~$.01 ~~antidilutive~~per share.

~~Beneficial~~The ~~Conversion Features. From time to time, the~~ Company ~~may~~has ~~issue~~ convertible promissory notes that ~~contain~~in ~~an imbedded beneficial conversion feature. A beneficial conversion feature exists on~~ the ~~date~~aggregate aresult ~~convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is~~ in ~~excess~~a ofprincipal ~~the~~outstanding ~~remaining~~balance ~~unallocated proceeds~~ of ~~the~~$157,945 ~~note after first considering the allocation~~ as of aOctober ~~portion~~31, of2021 ~~the~~and ~~note~~July ~~proceeds~~31, ~~to the fair value of warrants~~2021, ~~if related warrants have been granted~~respectively. ~~The~~Interest ~~intrinsic~~on ~~value~~these ofnotes ~~the~~range ~~beneficial~~from ~~conversion~~eight ~~feature~~to isten ~~recorded~~percent asper aannum ~~debt~~and ~~discount~~such notes ~~with~~had amaturity ~~corresponding~~dates ~~amount~~of toJuly 31, ~~additional paid in capital~~2015. The ~~debt~~principal ~~discount~~and isaccrued ~~amortized to~~ interest ~~expense~~is ~~over~~convertible, at the ~~life~~option of the ~~note~~holder, ~~using~~into ~~the~~common ~~effective~~shares ~~interest~~at ~~method~~$.04 per share.

~~Fair~~The ~~Value~~Company ofhas ~~Financial~~convertible ~~Instruments. On~~promissory notes ~~August~~that 1in the aggregate result in a principal outstanding balance of $50,000 ~~2012~~as of October 31, ~~the~~2021 ~~Company~~and ~~adopted~~July ~~ASC~~31, ~~820~~2021, ~~Fair~~respectively. Interest ~~Value~~on ~~Measurements~~these notes are 8% per annum and ~~Disclosures~~such ~~("ASC~~notes ~~820")~~had maturity date of March 31, 2015. ~~ASC~~ ~~820~~The ~~defines~~principal ~~fair~~and ~~value~~accrued interest is convertible, at ~~establishes~~the aoption ~~three~~of the holder, into non-~~level~~restricted ~~valuation~~common ~~hierarchy~~stock ~~for~~in ~~disclosures~~an ofamount ~~fair~~equal ~~value~~to ~~measurement~~the ~~and~~total ~~enhances~~sum ~~disclosure~~due, ~~requirements~~based ~~for~~on ~~fair~~a ~~value~~mutually ~~measures.~~agreed ~~The~~discount (not ~~three~~to ~~levels~~exceed ~~are~~50%) ~~defined~~to asthe ~~follows:~~then market price.

·The ~~Level~~Company 1has ~~inputs~~convertible topromissory notes that in the ~~valuation~~aggregate ~~methodology~~result in a principal outstanding balance of $44,711 as of October 31, 2021 and July 31, 2021, respectively. Interest on these notes are ~~quoted~~10% ~~prices~~per ~~(unadjusted)~~annum ~~for~~and ~~identical~~such ~~assets~~notes orhad ~~liabilities~~maturity indates ~~active~~ranging ~~markets~~from July 31, 2015 to December 31, 2015. The principal and accrued interest is convertible, at the option of the holder, into common shares at $.07 per share.

·The ~~Level~~Company 2has ~~inputs~~convertible topromissory notes that in the ~~valuation~~aggregate ~~methodology~~result ~~include~~in ~~quoted~~a ~~prices~~principal ~~for~~outstanding ~~similar~~balance ~~assets~~of ~~and~~$39,000 ~~liabilities~~as inof ~~active~~October ~~markets~~31, 2021 and ~~inputs~~July ~~that~~31, 2021, respectively. Interest on these notes are ~~observable~~10% ~~for~~per ~~the~~annum ~~asset~~and orsuch ~~liability~~notes had maturity dates ranging from July 31, ~~either~~2015 ~~directly~~to orDecember ~~indirectly~~31, ~~for~~2015. ~~substantially~~The ~~the~~principal and ~~full~~accrued ~~term~~interest is convertible, at the option of the ~~financial~~holder, ~~instrument~~into common shares at $.10 per share.

·Accrued ~~Level~~interest 3on ~~inputs~~such tonotes ~~valuation~~total $388,129 ~~methodology~~and ~~are~~$375,504 ~~unobservable~~as of October 31, 2021 and ~~significant~~July to31, 2021, respectively and are included within accrued liabilities on the ~~fair~~accompanying balance ~~measurement~~sheet. Based on the maturity dates of the promissory notes, all promissory notes are in default.

The following table represents our assets and liabilities by level measured at fair value on a recurring basis at April 30, 2015:

Description

Level 1

Level 2

Level 3

Total Realized Loss

Totals

New Accounting Pronouncements

In June 2014, the FASB issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. The new guidance requires that share-based compensation that requires a specific performance target to be achieved in order for employees to become eligible to vest in the awards and that could be achieved after an employee completes the requisite service period be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant-date fair value of the award. Compensation costs should be recognized in the period in which it becomes probable that the performance target will be achieved

~~WORLDWIDE~~Note ~~STRATEGIES~~6 ~~INCORPORATED~~– Shareholders’ Equity

~~Notes~~Preferred ~~to Consolidated Financial Statements~~stock

~~(Unaudited)~~The Company has two classes of preferred stock and is authorized to issue 25,000,000 shares of $.001 par value preferred stock. The Company's Board of Directors may divide and issue the preferred shares in series. Each Series, when issued, shall be designated to distinguish them from the shares of all other series. The relative rights and preferences of these series include preference of dividends, redemption terms and conditions, amount payable upon shares of voluntary or involuntary liquidation, terms and condition of conversion as well as voting powers.

~~and~~Series ~~should~~A ~~represent~~Preferred ~~the~~Stock compensation cost attributable to the period(s) for which the requisite service has already been rendered. If the performance target becomes probable of being achieved before the end of the requisite service period, the remaining unrecognized compensation cost should be recognized prospectively over the remaining requisite service period. The total amount of compensation cost recognized during and after the requisite service period should reflect the number of awards that are expected to vest and should be adjusted to reflect those awards that ultimately vest. The requisite service period ends when the employee can cease rendering service and still be eligible to vest in the award if the performance target is achieved. This new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2015. Early adoption is permitted. Entities may apply the amendments in this Update either (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. The early adoption of ASU 2014-12 is not expected to have a material impact on our financial position or results of operations.

InThe ~~June~~Company ~~2014,~~is ~~the~~authorized ~~FASB~~to ~~issued~~issue ~~ASU 2014-10~~5,000,000 shares ~~Development~~of ~~Stage~~Convertible ~~Entities.~~Series ~~The~~A ~~amendments~~Preferred inStock ~~this~~at ~~update remove the definition of~~ a ~~development~~par ~~stage~~value ~~entity from the Master Glossary~~ of ~~the ASC thereby removing the financial reporting distinction between development stage entities and other reporting entities from U~~$0.S001. ~~GAAP.~~Each Inshare ~~addition,~~of ~~the~~Series ~~amendments~~A ~~eliminate~~Preferred ~~the~~Stock ~~requirements~~is ~~for~~convertible ~~development~~into ~~stage~~6.25 shares ~~entities to (1) present inception-to-date information in the statements~~ of ~~income,~~common ~~cash~~stock ~~flows,~~at ~~and shareholder equity, (2) label~~ the ~~financial~~election ~~statements as those~~ of ~~a development stage entity, (3) disclose a description of~~ the ~~development~~holder. ~~stage~~Each ~~activities~~Series inA ~~which~~share ~~the entity~~ is ~~engaged,~~entitled ~~and~~to ~~(4)~~6.25 ~~disclose~~votes in ~~the~~any ~~first~~vote ~~year~~of ~~in which~~ the ~~entity~~common isstock noholders. Series ~~longer~~A ashares ~~development~~are ~~stage~~redeemable ~~entity~~by ~~that~~the inCompany ~~prior~~at ~~years~~$.50 itper ~~had~~share ~~been~~with in15 ~~the~~days ~~development~~written ~~stage~~notice. ~~The~~Series ~~amendments~~A inshares ~~this update~~ are ~~applied~~entitled ~~retrospectively.~~to ~~The~~a ~~early~~5% ~~adoption~~dividend preference ofand ~~ASU~~a ~~2014-10~~participation ~~removed~~interest in the ~~development~~remaining ~~stage~~95% ~~entity financial reporting requirements from the Company~~dividend.

InSeries ~~July~~B ~~2013,~~Preferred ~~the~~Stock FASB issued ASU No. 2013-11: Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry forward, a Similar Tax Loss, or a Tax Credit Carry forward Exists. The new guidance requires that unrecognized tax benefits be presented on a net basis with the deferred tax assets for such carry forwards. This new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2013. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

~~(2) Accounts~~The ~~payable~~Company ~~related~~is ~~parties~~authorized to issue 5,000,000 shares of Convertible Series B Preferred Stock at a par value of $0.001. Each share of Series B Preferred Stock is convertible into 1,000 shares of common stock at the election of the holder.

AtCommon ~~April 30, 2015 and July 31, 2014, the Company was indebted to an officer for expenses incurred on behalf of the Company totaling $3,900.~~stock

~~(3) Related~~As ~~party~~of ~~transactions~~October 31, 2021 and July 31, 2021, the Company was authorized to issue 975,000,000 shares of common stock respectively. Total shares outstanding at October 31, 2021 and July 31, 2021 were 19,830,679, respectively.

~~Accrued~~Note ~~liabilities~~7 - Income taxes

~~During~~The ~~the~~Company ~~nine-month~~accounts ~~period~~for ~~ended~~income ~~April~~taxes under 30FASB ASC Topic 740, ~~2015~~which requires use of the liability method. FASB ASC Topic 740 provides that deferred tax assets and liabilities are recorded based on the ~~fiscal~~differences ~~year~~the ~~ended~~tax ~~July~~basis of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences. As of October 31, ~~2014~~2021, ~~accrued~~the ~~liabilities~~Company ~~related~~incurred ~~parties~~a ~~totaled~~net ~~$28,659~~operating loss and, ~~$18~~accordingly,~~041~~ ~~respectively. The~~no ~~increase~~provision for ofincome ~~$10~~taxes has been recorded. In addition,~~618~~ ~~represents~~no ~~accrued~~benefit ~~interest~~for ~~expense~~income ontaxes ~~notes~~has ~~payable~~been recorded due to ~~related~~the ~~parties~~uncertainty ~~during~~of the ~~period~~realization of any tax assets.

~~Notes~~Based ~~payable~~on the available objective evidence, including the Company's history of losses, management believes it is more likely than not, the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at October 31, 2021 and July 31, 2021. The Company had no uncertain tax positions as of October 31, 2021 and July 31, 2021.

During May 2010, the Company issued a convertible promissory note to a related party in exchange for $50,000. The note bears interest at 9% and the principal and accrued interest is convertible into common shares at $.04 per share upon the election of the holder. The note also provides for renewal in 120-day cycles, assuming issuing of common stock as a renewal premium. This note was exchanged in April 2013 for new promissory notes bearing interest at 10% and convertible into common shares at $.01 per share with a 120-day renewal cycle and identical renewal premium. The new promissory notes allow the Company to call the note and pay it off, a feature not available in the prior promissory note.

~~WORLDWIDE~~Note ~~STRATEGIES~~8 ~~INCORPORATED~~– Acquisition

~~Notes~~On May 29, 2021, the Company entered into a binding letter of intent (the “LOI”) with Fitwell Limited a company organized under the laws of the United Kingdom (“Fitwell”) to ~~Consolidated~~acquire ~~Financial~~Fitwell ~~Statements~~and its fitness and nutrition app, that same letter of intent expired, pursuant to the terms therein on July 29, 2021.

Subsequent thereto, on September 24, 2021, the Company entered into a contingent Stock Purchase Agreement (~~Unaudited~~the “Agreement”) with Fitwell pursuant to which we have agreed to acquire one hundred percent of issued and outstanding shares of Fitwell for a purchase price of $1,000,000 payable in cash and our common stock. Worldwide Strategies will pay an aggregate cash purchase price of $500,000 and will issue shares of the Registrant’s common stock valued at $500,000 with the price per share being the price that we price our shares for sale in our planned Regulation A+ offering (“the Offering”), notwithstanding, the price of the offering, the price per share of the shares to be issued to Fitwell shall not exceed a per share price of $0.40. The acquisition is contingent on our conducting a Regulation A+ offering, wherein we raise a minimum of $2,000,000 (the “Offering”).

~~During~~The ~~December~~Fitwell ~~2010,~~shareholders will receive the ~~Company~~cash ~~issued~~component aof ~~convertible~~our ~~promissory~~purchase ~~note~~price tofrom athe ~~related~~proceeds ~~party~~of inour ~~exchange~~Offering ~~for $15,000. The note bears interest at 9%~~ and the ~~principal~~shares ~~and~~to ~~accrued~~be ~~interest~~issued isshall ~~convertible~~be ~~into~~issued subsequent ~~common~~to ~~shares at $.04 per share upon~~ the ~~election~~closing of the ~~holder~~Offering. ~~The~~In ~~note~~connection ~~also~~with ~~provides~~the ~~for~~Buyer’s ~~renewal~~acquisition inof ~~120-day~~the ~~cycles~~Business, ~~assuming~~the ~~issuing~~Buyer ofand ~~common~~the Seller ~~stock~~will asenter ~~a renewal premium. This note was exchanged in April 2013 for new promissory notes bearing interest at 10% and convertible~~ into ~~common~~customary ~~shares~~transition atservices ~~$.01 per share with a 120-day renewal cycle~~ and ~~identical~~other ~~renewal~~ancillary ~~premium~~arrangements. The ~~new~~Agreement ~~promissory~~also ~~notes~~contains representations, ~~allow~~warranties, ~~the~~covenants, ~~Company~~indemnification toobligations ~~call the note~~ and ~~pay~~closing itconditions ~~off,~~which aare ~~feature~~customary ~~not~~for ~~available~~transactions inof this ~~the prior promissory note~~nature.

~~During~~The ~~May~~Buyer ~~2011,~~and the ~~Company~~Seller ~~issued~~have ~~two~~the right ~~convertible~~to ~~promissory~~terminate ~~notes~~the Agreement prior to ~~related~~the ~~parties~~closing inunder ~~exchange~~certain ~~for~~circumstances, aincluding, ~~total~~without oflimitation: ~~$4,000. The~~(i) by ~~notes~~mutual written ~~bear~~consent; ~~interest~~(ii) by ateither ~~10%~~the ~~and~~Buyer or the ~~principal~~Seller ~~and~~if ~~accrued~~the ~~interest~~closing ishas ~~convertible~~not ~~into~~occurred ~~common~~on ~~shares~~or atbefore ~~$.07~~the ~~per~~date ~~share~~that ~~upon~~is 90 days following the ~~election~~qualification of the ~~holder. In~~Registrant’s ~~November~~offering ~~2011~~by ~~these~~the ~~notes~~Securities ~~were~~and ~~exchanged~~Exchange ~~for~~Commission; ~~new~~(iii) by ~~convertible~~the ~~promissory~~Seller if ~~notes~~the ~~totaling~~Offering does not raise a minimum of $42,~~173~~000,000 in ~~principal~~proceeds or (iv) by either the Buyer or the Seller if a material breach occurs and ~~accrued~~is ~~interest~~not cured within the required amount of time.

During November 2011, the Company issued two convertible promissory notes to related parties in exchange for $4,173 of principal and accrued interest on due promissory notes. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holders, as did the notes being replaced. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $2,340, all of which was amortized in the fiscal year ending July 31, 2012. The original maturity date on these notes was April 30, 2012. The holders have extended both notes to July 31, 2015.

During April 2012, the Company issued a convertible promissory note to a related party in exchange for a total of $5,000. The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.04 per share upon the election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $1,250, $831 of which was amortized in the fiscal year ended July 31, 2012 and the remaining $419 amortized in the fiscal year ending July 31, 2013. The original maturity date on this note was September 30, 2012. The holder has extended the note to July 31, 2015.

During December 2012, the Company issued two promissory notes to two related parties totaling $2,000. The notes bear interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $2,000, all of which was amortized in the fiscal year ending July 31, 2013. The original maturity date on these notes was June 30, 2013. The holders have extended the notes to July 31, 2015.

During February 2013, the Company issued one promissory note to a related party for $500. The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share. This note was related to company expenses paid. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $500, $427 of which was amortized in the fiscal year ended July 31, 2013 and the remaining $73 amortized in the fiscal year ending July 31, 2014. The original maturity date on this note was August 31, 2013. The holder has extended the note to July 31, 2015.

During April 2013, the Company issued five convertible promissory notes to related parties in exchange for two promissory notes totaling $65,000. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder. These notes have a 120-day term and are renewed with payment of accrued interest in common stock as well as a renewal fee of 455,000 shares. The common shares for this renewal fee were issued May 14, 2013 and valued at $13,577. These notes were replaced through renewal in July 2013.

During July 2013, the Company issued one promissory note to a related party for $28,500. The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share. This note was in exchange for accrued and owed salary of $241,875 and accrued and owed expense of $108,844. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $28,500, all of which was amortized in the fiscal year ended July 31, 2014. The original maturity date on this note was January 31, 2014. The holder has extended the note to July 31, 2015.

~~WORLDWIDE~~Item ~~STRATEGIES~~2. ~~INCORPORATED~~Management’s Discussion and Analysis of Financial Condition and Results of Operations

~~Notes~~Cautionary toStatement ~~Consolidated~~Regarding ~~Financial~~Forward-Looking Statements

This report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (~~Unaudited~~the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward looking statements. Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. The words “may,” “will,” “anticipate,” “should,” “would,” “believe,” “contemplate,” “could,” “project,” “predict,” “expect,” “estimate,” “continue,” and “intend,” as well as other similar words and expressions of the future, are intended to identify forward-looking statements.

~~During~~Factors ~~July~~that ~~2013,~~may ~~the~~cause ~~Company~~actual ~~issued~~results to ~~one~~differ ~~promissory~~from ~~note~~those toresults aexpressed ~~related~~or ~~party~~implied, ~~for $17~~include,~~000. The~~ ~~note~~but ~~bears interest at 10% and the principal and accrued interest~~ are ~~convertible~~not ~~into~~limited ~~common~~to, ~~shares~~those atlisted ~~$.01~~under ~~per~~“Risk ~~share. This~~Factors” ~~note was~~ in ~~exchange~~our Registration ~~for~~Statement ~~accrued and owed salary of $168,750 to the Company's former CFO. Based~~ on ~~the~~Form ~~initial~~10-K ~~valuation~~for of the ~~beneficial conversion feature the Company has recorded a debt discount of $17,000, all of which was amortized in the fiscal~~ year ended July 31, ~~2013. The~~2021 ~~original~~filed ~~maturity~~by ~~date~~the onCompany ~~this~~with ~~note~~the ~~was~~Securities ~~January~~and ~~31,~~Exchange ~~2014. The holder has extended~~ Commission (the ~~note~~“SEC”) toon ~~July~~October 3129, ~~2015~~2021.

~~During~~These ~~July~~forward-looking ~~2013,~~statements ~~the~~generally relate ~~Company~~to ~~issued~~our ~~five~~plans, ~~convertible~~objectives ~~promissory~~and ~~notes~~expectations tofor ~~related~~future ~~parties~~events inand ~~exchange~~include ~~for~~statements ~~five~~about ~~promissory~~our ~~notes~~expectations, ~~totaling~~beliefs, ~~$65~~plans,~~000.~~ ~~The~~objectives, intentions, ~~notes~~assumptions ~~bear~~and ~~interest~~other atstatements ~~10%~~that ~~and~~are ~~the~~not ~~principal~~historical ~~and~~facts. These ~~accrued~~statements ~~interest~~are isbased ~~convertible~~upon ~~into~~our ~~common~~opinions ~~shares~~and estimates atas ~~$.01~~of ~~per~~the ~~share~~date ~~upon~~they ~~the~~are ~~election~~made. ofAlthough we believe that the ~~holder. These~~expectations ~~notes~~reflected ~~have~~in athese ~~120~~forward-~~day~~looking ~~term~~statements are ~~and~~reasonable, ~~are~~such ~~renewed~~forward-looking ~~with~~statements ~~payment~~are ofsubject ~~accrued~~to ~~interest~~known inand ~~common~~unknown ~~stock~~risks asand ~~well~~uncertainties asthat amay ~~renewal~~be ~~fee~~beyond ofour ~~455~~control,~~000~~ which ~~shares. The~~could ~~common~~cause ~~shares~~actual ~~for~~results, ~~this~~performance ~~renewal~~and ~~fee~~achievements ~~were~~to ~~issued~~differ ~~August~~materially 5from results, ~~2013~~performance and ~~valued~~achievements ~~at $26~~projected,~~845~~ expected, expressed or implied by the forward-looking statements. ~~These~~ ~~notes~~While ~~matured~~we ~~December~~cannot 11assess the future impact that any of these differences could have on our business, ~~2013~~financial condition, results of operations and cash flows or the ~~holders~~market ~~chose~~price ~~not~~of toshares ~~renew~~of ~~per~~our common stock, the ~~note~~differences ~~terms~~could be significant. ~~The~~ ~~notes~~You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in ~~default~~this report and you ~~payable~~are onurged ~~demand~~to consider all such risks and uncertainties. In light of the ~~holders~~uncertainty inherent in such forward-looking statements, you should not consider their inclusion to be a representation that such forward-looking matters will be achieved.

~~During~~General December 2013, the Company issued two promissory notes to two related parties totaling $16,000. The notes bear interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $16,000, all of which was amortized in the fiscal year ending July 31, 2014. The original maturity date on these notes was May 31, 2014. The holders have extended the notes to July 31, 2015.Overview

~~During~~Results June 2014, the Company issued one promissory note to a related party for $2,000. The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $2,000, $659 of which was amortized in the fiscal year ended July 31, 2014 and the remainder amortized in the nine-month period ending April 30, 2015. The original maturity date on this note was November 30, 2014. The holder has extended the note to July 31, 2015.operations

InThree ~~September~~months ~~2014,~~ended ~~the~~October ~~Company~~31, ~~issued~~2021 ~~two convertible promissory notes~~ compared to ~~two related parties in exchange for $1,750. The notes bear interest at 10% and~~ the ~~principal~~three ~~and~~months accrued interest are convertible into common shares at $.01 per share upon election of the holders. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $1,750, $1,233 of which was amortized in the nine-month period ended ~~April~~October ~~30, 2015. The original maturity date on these notes is July~~ 31, ~~2015.~~2020

AsNet of April 30, 2015, the Company had outstanding convertible promissory notes to related parties totaling $141,924. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares, with $4,173 convertible at $.07 per share, $70,000 convertible at $.04 per share and $67,750 convertible at $.01 per share upon the election of the holder. Interest expense for these notes was accrued in the amount of $10,618 for the nine-month period ended April 30, 2015.Loss

~~Common~~For ~~Stock~~the three months ended October 31, 2021 and 2020 we incurred net losses of approximately $26,000 and $12,000 respectively.

In August 2012, the Company issued 116,250 shares of the Company's common stock in exchange for accrued interest and an extension of due date from July 25, 2012 to November 22, 2012 on a note payable. The shares related to the accrued interest were issued at $.04 per share and the shares related to the extension were issued at $.01 per share (fair market value) on the day they were granted, per the terms of the agreement. This amount ($1,500) is reflected in the accompanying financial statements as interest.Revenue

InFor ~~September 2012,~~ the ~~Company~~three ~~issued~~months ~~387,500~~ended October ~~shares of the Company's common stock in exchange for accrued interest and an extension of due date from September 12~~31, ~~2012~~2021 ~~to January 10, 2013 on a note payable. The shares related to the accrued interest were issued at $.04 per share~~ and ~~the shares related to the extension were issued at $.01 per share (fair market value) on the day they were granted~~2020, ~~per~~we ~~the~~generated ~~terms~~no ~~of the agreement~~revenue. ~~This amount ($5,000) is reflected in the accompanying financial statements as interest.~~

Expenses

For the three months ended October 31, 2021 we incurred expenses of approximately $26,000 of which approximately $14,000 was primarily related to professional fees and $12,000 was primarily related to interest expense.

For the three months ended October 31, 2020 we incurred expenses of approximately $12,000 which was primarily related to professional fees.

~~WORLDWIDE~~Financial ~~STRATEGIES INCORPORATED~~condition

~~Notes~~Liquidity toand ~~Consolidated~~Capital ~~Financial Statements~~Resources

~~(Unaudited)~~Currently, we rely on our management to provide us with the capital needed to run our business on a day-to-day basis.

InFor ~~December~~the ~~2012,~~three ~~the~~months ~~Company~~ended ~~issued~~October ~~116~~31,~~250~~ ~~shares~~2021 ofand ~~the~~2020 ~~Company's~~we ~~common~~incurred net ~~stock~~losses ~~in exchange for accrued interest and an extension~~ of ~~due~~approximately ~~date from November 22~~$26,000 ~~2012~~and ~~to January 10~~$12,000 ~~2013 on a note payable~~respectively. ~~The~~As ~~shares~~of ~~related~~October to31, ~~the~~2021 ~~accrued~~we ~~interest~~had ~~were~~no ~~issued~~cash aton ~~$.04~~hand ~~per share~~ and ~~the~~current ~~shares~~liabilities ~~related to the extension were issued at~~ of $0.039 ~~per~~million. ~~share~~As ~~(fair~~of ~~market~~July ~~value)~~21, on2021, ~~the~~we ~~day~~had ~~they~~no ~~were~~cash ~~granted,~~on ~~per~~hand ~~the~~and ~~terms~~current liabilities of ~~the agreement~~$0. ~~This~~9 ~~amount ($3,488) is reflected in the accompanying financial statements as interest~~million.

InWe ~~February~~will ~~2013,~~seek ~~the~~additional ~~Company~~funds ~~issued~~through ~~387,500~~equity ~~shares~~or ofdebt ~~the~~financing, collaborative ~~Company's~~or ~~common~~other ~~stock~~arrangements inwith ~~exchange~~corporate ~~for~~partners, ~~accrued~~licensees ~~interest~~or others, and ~~an extension of due date~~ from ~~January~~other 10sources, ~~2013~~which tomay ~~May~~have ~~10,~~the ~~2013~~effect onof diluting ~~a note payable. The shares related to~~ the ~~accrued~~holdings ~~interest~~of ~~were~~existing ~~issued~~shareholders. atThe ~~$.04~~Company ~~per~~has ~~share~~no ~~and~~current ~~the~~arrangements ~~shares~~with ~~related~~respect to, ~~the~~or ~~extension~~sources ~~were~~of, ~~issued~~such atadditional financing ~~$.03~~and ~~per~~we ~~share~~do ~~(fair~~not ~~market~~anticipate ~~value)~~that onexisting ~~the~~shareholders ~~day~~will ~~they~~provide ~~were~~any ~~granted,~~portion ~~per the terms~~ of ~~the~~our ~~agreement. This~~future ~~amount~~financing ~~($11,625) is reflected in the accompanying financial statements as interest~~requirements.

InNo ~~March~~assurance ~~2013,~~can ~~the~~be ~~Company~~given ~~issued~~that ~~116,250~~additional ~~shares~~financing ofwill be ~~the~~available ~~Company's~~when ~~common~~needed ~~stock~~or inthat ~~exchange~~such ~~for~~financing ~~accrued~~will ~~interest~~be ~~and~~available ~~an extension of due date from March 22, 2013 to July 20, 2013~~ on aterms ~~note~~acceptable ~~payable. The shares related~~ to the ~~accrued~~Company. ~~interest~~If ~~were~~adequate ~~issued~~funds atare ~~$.04~~not ~~per~~available, we ~~share~~may ~~and~~be ~~the~~required ~~shares related~~ to ~~the~~delay ~~extension~~or ~~were~~terminate ~~issued~~expenditures atfor ~~$.05~~certain ~~per~~of ~~share~~its ~~(fair~~programs ~~market~~that ~~value)~~it onwould ~~the~~otherwise ~~day~~seek ~~they~~to ~~were~~develop ~~granted,~~and ~~per the terms of the agreement~~commercialize. This ~~amount~~would ~~($3,600)~~have isa ~~reflected~~material inadverse ~~the~~effect ~~accompanying~~on ~~financial~~the ~~statements as interest~~Company.

InItem ~~May 2013, the Company issued 330,021 shares of the Company's common stock in exchange for accrued interest and an exchange for replacement on two notes payable~~3. ~~The~~Quantitative ~~shares related to the accrued interest were issued at $.04 per share~~ and ~~the~~Qualitative ~~shares~~Disclosures ~~related~~About toMarket the extension were issued at $.05 per share (fair market value) on the day they were granted, per the terms of the agreement. This amount ($16,182) is reflected in the accompanying financial statements as interest.Risk

InNot ~~August 2013, the Company issued 503,750 shares of the Company's common stock in exchange for accrued interest and an extension of due date on five notes payable~~required. The shares related to the accrued interest were issued at $.01 per share and the shares related to the extension were issued at $.06 per share (fair market value) on the day they were granted, per the terms of the agreement. This amount ($30,225) is reflected in the accompanying financial statements as interest.

In September 2013, the Company issued 167,917 shares of the Company's common stock in exchange for additional accrued interest on five notes payable. The shares related to the accrued interest were issued at $.01 per share and the shares related to the extension were issued at $.06 per share (fair market value) on the day they were granted, per the terms of the agreement. This amount ($10,075) is reflected in the accompanying financial statements as interest.

In March 2014, the Company issued 300,000 shares of common stocks to independent Directors as compensation for services provided. These shares, approved August 2011, were previously recorded as stock payable.

There were no issuances of Common Stock during the nine-month period ending April 30, 2015.

(4) Notes payable

During November 2009, the Company issued a convertible promissory note to an unrelated third party in exchange for $25,000. The note bears interest at 8% and the principal and accrued interest is convertible, at the option of the holder, into non-restricted common stock in an amount equal to the total sum due, based on a mutually agreed discount (not to exceed 50%) to the then market price. The original maturity date on this note was May 31, 2010. The holder has extended the note to July 31, 2015.

During February 2010, the Company issued a convertible promissory note to an unrelated third party in exchange for $25,000. The note bears interest at 8% and the principal and accrued interest is convertible, at the option of the holder, into non-restricted common stock in an amount equal to the total sum due, based on a mutually agreed discount (not to exceed 50%) to the then market price. The original maturity date on this note was July 31, 2010. The holder has extended the note to July 31, 2015.

WORLDWIDE STRATEGIES INCORPORATED

Notes to Consolidated Financial Statements

(Unaudited)

During October 2011, the Company issued a convertible promissory note to an unrelated party in exchange for $15,000. The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder. The original maturity date on this note was April 25, 2012. The holder has extended the note to July 31, 2015.

During November 2011, the Company issued a convertible promissory note to an unrelated party in exchange for $2,087 of principal and accrued interest on a due promissory note. The terms of the new note match those of the note being replaced. The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder, as did the notes being replaced. The original maturity date on this note was April 30, 2012. The holder has extended the note to July 31, 2015.

During March 2012, the Company issued a convertible promissory note to an unrelated party to replace a note due, including accrued interest, of $15,750. The terms of the new note match those of the note being replaced. The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder. The original maturity date on this note was August 31, 2012. The holder has extended the note to July 31, 2015.

During March 2012, the Company issued a convertible promissory note to an unrelated party in exchange for $2,150. The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder. The original maturity date on this note was September 12, 2012. The holder has extended the note to July 31, 2015.

During April 2012, the Company issued convertible promissory notes to four unrelated parties in exchange for a total of $12,000. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.04 per share upon the election of the holder of each note. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $4,750, $3,158 of which was amortized in the fiscal year ended July 31, 2012 and $1,592 amortized in the fiscal year ended July 31, 2013. The original maturity date on these notes was September 30, 2012. The holders have extended the notes to July 31, 2015.

During July 2012, the Company issued a convertible promissory note to an unrelated party in exchange for $15,000. The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder. The original maturity date on this note was January 31, 2013. The holder has extended the note July 31, 2015.

During October 2012, the Company issued convertible promissory notes to five unrelated parties in exchange for a total of $7,500. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder of each note. The original maturity date on these notes was March 31, 2013. The holders have extended the notes to July 31, 2015.

During January 2013, the Company issued three promissory notes to one unrelated party for a total of $12,500. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder of each note. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $12,500, all of which was amortized in the fiscal year ended July 31, 2013. The original maturity date on these notes was July 31, 2013. The holder has extended the notes to July 31, 2015.

During June 2013, the Company issued convertible promissory notes to three unrelated parties in exchange for a total of $8,500. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder of each note. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $8,500, $2,558 of which was amortized in the fiscal year ended July 31, 2013 and $5,942 amortized in the fiscal year ended July 31, 2014. The original maturity date on these notes was November 30, 2013. The holders have extended the notes to July 31, 2015.

During June 2013, the Company issued a convertible promissory note to an unrelated party valued at $3,550 as compensation for consulting services. The note bears interest at 10% and the principal and accrued interest is

WORLDWIDE STRATEGIES INCORPORATED

Notes to Consolidated Financial Statements

(Unaudited)

convertible into common shares at $.01 per share upon the election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $3,550, $848 of which was amortized in the fiscal year ended July 31, 2013 and $2,702 was amortized in the fiscal year ended July 31, 2014. The original maturity date on this note was December 31, 2013. The holder has extended the note to July 31, 2015.

During September 2013, the Company issued one promissory note to one unrelated party for a total of $3,000. The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $3,000, all of which was amortized in the fiscal year ended July 31, 2014. The original maturity date on this note was February 28, 2014. The holder has extended the note to July 31, 2015.

During December 2013, the Company issued four promissory notes to four unrelated parties for a total of $8,000. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder of each note. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $8,000, all of which was amortized in the fiscal year ended July 31, 2014. The original maturity date on these notes was May 31, 2014. The holders have extended the notes to July 31, 2015.

During December 2013, the Company issued one promissory note to one unrelated party for a total of $5,000. The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $5,000, all of which was amortized in the fiscal year ended July 31, 2014. The original maturity date on this note was June 30, 2014. The holder has extended the note to July 31, 2015.

During December 2013, the Company issued one promissory note to one unrelated party for a total of $2,000. The note bears interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $2,000, all of which was amortized in the fiscal year ended July 31, 2014. The original maturity date on this note was June 30, 2014. The holder has not extended the note and the note is in default.

During January 2014, the Company issued two promissory notes to two unrelated party for a total of $4,000. The notes bear interest at 10% and the principal and accrued interest is convertible into common shares at $.01 per share upon the election of the holder of each note. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $4,000, all of which was amortized in the fiscal year ended July 31, 2014. The original maturity date on the notes was June 30, 2014. The holders have extended the notes to July 31, 2015.

During June 2014, the Company issued one promissory note to one unrelated party for $2,000. The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $2,000, $659 of which was amortized in the fiscal year ended July 31, 2014 and the remainder amortized in the nine-month period ending April 30, 2015. The original maturity date on this note was November 30, 2014. The holder has extended the note to July 31, 2015.

In October 2014, the Company issued a convertible promissory note to an unrelated party in exchange for $40,000. The note bears interest at 8% and the principal and accrued interest are convertible into common shares at $.04 per share upon election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $10,000, $6,737 of which was amortized in the nine-month period ended April 30, 2015. The original maturity date on this note is July 31, 2015.

In November 2014, the Company issued one convertible promissory note to an unrelated party in exchange for services valued at $4,000. The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share upon election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $4,000, $2,647 of which was amortized in the nine-month period ended April 30, 2015. The original maturity date on this note is July 31, 2015.

WORLDWIDE STRATEGIES INCORPORATED

Notes to Consolidated Financial Statements

(Unaudited)

In November 2014, the Company issued one convertible promissory note to an unrelated party in exchange for $20,000. The note bears interest at 8% and the principal and accrued interest are convertible into common shares at $.04 per share upon election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $5,000, $3,203 of which was amortized in the nine-month period ended April 30, 2015. The original maturity date on this note is July 31, 2015.

In December 2014, the Company issued one convertible promissory note to an unrelated party in exchange for services value at $2,000. The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share upon election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $2,000, $1,240 of which was amortized in the nine-month period ended April 30, 2015. The original maturity date on this note is July 31, 2015.

In December 2014, the Company issued one convertible promissory note to an unrelated party in exchange for $15,000. The note bears interest at 8% and the principal and accrued interest are convertible into common shares at $.04 share upon election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $3,750, $2,171 of which was amortized in the nine-month period ended April 30, 2015. The original maturity date on this note is July 31, 2015.

In January 2015, the Company issued one convertible promissory note to an unrelated party in exchange services valued at $2,000. The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share upon election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $2,000, $1,128 of which was amortized in the nine-month period ended April 30, 2015. The original maturity date on this note is July 31, 2015.

In January 2015, the Company issued one convertible promissory note to an unrelated party in exchange for services valued at $30,000. The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.10 per share upon election of the holder. The original maturity date on this note is July 31, 2015.

In March 2015, the Company issued one convertible promissory note to an unrelated party in exchange for $12,500. The note bears interest at 8% and the principal and accrued interest are convertible into common shares at $.04 share upon election of the holder. Based on the initial valuation of the beneficial conversion feature the Company has recorded a debt discount of $3,156, $923 of which was amortized in the nine-month period ended April 30, 2015. The original maturity date on this note is July 31, 2015.

(5) Shareholders' Deficit

Preferred stock

The Company is authorized to issue 25,000,000 shares of $.001 par value preferred stock. The Company's Board of Directors may divide and issue the preferred shares in series. Each Series, when issued, shall be designated to distinguish them from the shares of all other series. The relative rights and preferences of these series include preference of dividends, redemption terms and conditions, amount payable upon shares of voluntary or involuntary liquidation, terms and condition of conversion as well as voting powers.

There were no issuances of Preferred Stock during the nine-month period ending April 30, 2015 and the year ending July 31, 2014.

Common stock

The Company is authorized to issue 33,333,333 shares of common stock. Total shares outstanding at the nine-month period ending April 30, 2015 and fiscal year ending July 31, 2014 were 19,830,672.

There were no issuances of Common Stock during the nine-month period ending April 30, 2015.

WORLDWIDE STRATEGIES INCORPORATED

Notes to Consolidated Financial Statements

(Unaudited)

Stock Options and Warrants

Effective February 1, 2006, the Company adopted ASC 718 Stock Based Payment which requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions).

In August 2012, the Company granted the CEO and four directors options to purchase an aggregate of 500,000 shares of the Company's common stock at an exercise price of $.01 per share, in exchange for unpaid services expenses. All 500,000 options were fully vested on the grant date. The quoted market price of the stock was $.01 per share on the grant date. The Company valued the options at $.01 per share, or $5,000. This amount is reflected in the year ended July 31, 2013 financial statements as stock based compensation. The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate	0.63%
Dividend yield	0.00%
Volatility factor	273.47%
Weighted average expected life	7 years

In August 2012, the Company granted the VP Finance & CFO options to purchase an aggregate of 150,000 shares of the Company's common stock at an exercise price of $.01 per share, in exchange for unpaid services expenses. All 150,000 options were fully vested on the grant date. The quoted market price of the stock was $.01 per share on the grant date. The Company valued the options at $.01 per share, or $1,500. This amount is reflected in the year ended July 31, 2013 financial statements as stock based compensation. The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate	0.45%
Dividend yield	0.00%
Volatility factor	271.79%
Weighted average expected life	7 years

In July 2013, the Company granted the CEO and four directors options to purchase an aggregate of 500,000 shares of the Company's common stock at an exercise price of $.05 per share, in exchange for unpaid services expenses. All 500,000 options were fully vested on the grant date. The quoted market price of the stock was $.12 per share on the grant date. The Company valued the options at $.12 per share, or $60,000. This amount is reflected in the year ended July 31, 2013 financial statements as stock based compensation. The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate	0.59%
Dividend yield	0.00%
Volatility factor	314.40%
Weighted average expected life	5 years

In January 2015, the Company granted an unrelated party options to purchase an aggregate of 100,000 shares of the Company's common stock at an exercise price of $.01 per share, in exchange for services rendered. All 100,000 options were fully vested on the grant date. The quoted market price of the stock was $.05 per share on the grant date. The Company valued the options at $4,995. This amount is reflected in the accompanying financial statements as professional fees. The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate	1.18%
Dividend yield	0.00%
Volatility factor	611.62%
Weighted average expected life	5 years

WORLDWIDE STRATEGIES INCORPORATED

Notes to Consolidated Financial Statements

(Unaudited)

In February 2015, the Company granted the CEO and VP Finance & CFO options to purchase an aggregate of 900,000 shares of the Company's common stock at an exercise price of $.05 per share, in exchange for unpaid services expenses. All 900,000 options were fully vested on the grant date. The quoted market price of the stock was $.05 per share on the grant date. The Company valued the options at $44,902. This amount is reflected in the nine-months ended April 30, 2015 financial statements as stock based compensation. The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate	1.56%
Dividend yield	0.00%
Volatility factor	386.99%
Weighted average expected life	5 years

(6) Income Taxes

The Company accounts for income taxes under FASB ASC Topic 740, which requires use of the liability method. FASB ASC Topic 740 provides that deferred tax assets and liabilities are recorded based on the differences the tax basis of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences. The Company incurred net operating losses during all periods presented resulting in a deferred tax asset, which was fully allowed for; therefore, the net benefits and expense resulted in $0 income taxes.

(7) 10-Q Subsequent Event

In May 2015, the Company issued one convertible promissory note to an unrelated party in exchange for $15,025.12. The note bears interest at 8% and the principal and accrued interest are convertible into common shares at $.04 per share.

In May 2015, the Company issued one convertible promissory note to an unrelated party in exchange for services valued at $9,000. The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.10 per share.

In May 2015, the Company issued one convertible promissory note to an unrelated party in exchange for services valued at $2,250. The note bears interest at 10% and the principal and accrued interest are convertible into common shares at $.01 per share.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

General

The following discussion and analysis should be read in conjunction with our financial statements and related footnotes for the year ended July 31, 2014 included in our Annual Report on Form 10-K. The discussion of results, causes and trends should not be construed to imply any conclusion that such results or trends will necessarily continue in the future.

Overview

On July 8, 2005, pursuant to a Share Exchange Agreement with Worldwide Business Solutions Incorporated, a Colorado corporation ("WBSI"), we acquired all of the issued and outstanding capital stock of WBSI, in exchange for 2,573,335 shares of our common stock. As a result of this share exchange, shareholders of WBSI as a group owned approximately 76.8% of the shares then outstanding, and WBSI became our wholly-owned subsidiary.

For accounting purposes, the acquisition of WBSI has been accounted for as a recapitalization of WBSI. Since we had only minimal assets and no operations, the recapitalization has been accounted for as the sale of 778,539 shares of WBSI common stock for our net liabilities at the time of the transaction. Therefore, the historical financial information prior to the date of the recapitalization is the financial information of WBSI.

Effective July 31, 2007, we filed a Certificate of Change Pursuant to NRS 78.209, which decreased the number of our authorized shares of common stock from 100,000,000 to 33,333,333 and reduced the number of common shares issued and outstanding from 17,768,607 to 5,923,106. All shares and per share amounts in our consolidated financial statements and related notes have been retroactively adjusted to reflect the one-for-three reverse stock split for all periods presented.

On July 31, 2007, we acquired 100% of the issued and outstanding shares of Centric in exchange for 2,250,000 shares of our common stock. As a result of the acquisition, Centric became our wholly-owned subsidiary and the results of its operations have been included in our consolidated financial statements since the date of acquisition.

The company is finalizing plans to file to increase the number of authorized shares of common stock from 33,333,333 to 600,000,000 so that the stock exchange agreement entered into on December 14, 2012 with Jorge Zamacona Pliego, the President of Euzkadi Corporation of America S.A. de C.V. ("Euzkadi") and other principal owners of Euzkadi ("Euzkadi Principals") can be consummated.

We currently devote substantially all of our efforts to financial planning, raising capital and developing markets as we continue to be in the development stage.

Plan of Operations

As of the date hereof, we do not have any plans for business operations, merger or acquisition, other than the proposed business combination transaction with Euzkadi. While efforts continue, we have been unable to consummate this transaction since the stock exchange agreement entered into on December 14, 2012. We cannot assure you that this transaction will be completed.

We must raise additional capital to support our ongoing existence while we search for other merger opportunities. We cannot assure you that we will be able to complete additional financings successfully.

Significant Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires us to

make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to the valuation of accounts receivable and inventories, the impairment of long-lived assets, any potential losses from pending litigation and deferred tax assets or liabilities. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above-described items, are reasonable.

Development Stage. In June 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-10: Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements to improve financial reporting by reducing cost and complexity associated with the incremental reporting requirements of development stage entities. The changes eliminate the need for inception to date reporting and other disclosure requirement. The amendments are effective for annual reporting periods beginning after December 15, 2014. Early adoption is permitted. The Company has elected early adoption of these amendments.

Stock-based Compensation. The Company accounts for all stock-based payments to employees and non-employees under Accounting Standards Codification (ASC) 718 Stock Compensation, using the fair value based method. Under the fair value method, stock-based payments are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The cost of stock-based payments to non-employees that are fully vested and non-forfeitable at the grant date is measured and recognized at that date.

Loss per common share. We report net loss per share using a dual presentation of basic and diluted loss per share. Diluted net loss per share utilizes the average market price per share when applying the treasury stock method in determining common stock equivalents. As of April 30, 2015, there were 2,600,000 vested common stock options outstanding, which were excluded from the calculation of net loss per share-diluted because they were antidilutive.

Beneficial Conversion Features. From time to time, the Company may issue convertible notes that contain an imbedded beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.

New accounting pronouncements

Note 1 to the consolidated financial statements includes a complete description of new accounting pronouncements applicable to our Company.

Results of Operations

Three Months Ended April 30, 2015 and 2014. Professional and consulting fees totaled $76,736 and $3,050 for the three-month periods ended April 30, 2015 and 2014, respectively. Expenses in 2015 were significantly higher due to expenses related to bring the Company's tax and SEC filings current, $4,500 of executive support paid to the Company's and stock based compensation totaling $44,902. The Company granted the CEO and VP Finance & CFO options to purchase an aggregate of 900,000 shares of the Company's common stock at an exercise price of $.05 per share, in exchange for unpaid services expenses.

Travel expenses totaled $1,147 and $-0- for the three-month periods ended April 30, 2015 and 2014, respectively. Travel activity has increased in 2015 in support of business needs and activity.

Insurance expenses totaled $9,600 and $-0- for the three-month periods ended April 30, 2015 and 2014, respectively. The Company secured a Directors & Officers liability policy in 2015.

Other general and administrative expenses totaled $11,463 and $966 during the three-month periods ended April 30, 2015 and 2014, respectively. The increase in 2015 is related to notification of an IRS penalty due to late filing of the 2010 tax return. This penalty has been contested.

We recorded interest expense of $20,959 and $25,203 for the three-month periods ended April 30, 2015 and 2014, respectively. These charges include both interest expense as well as the Beneficial Conversion Feature amortization charge.

Our net loss was $119,905 and $29,219 for three-month periods ended April 30, 2015 and 2014, respectively.

Nine Months Ended April 30, 2015 and 2014. Professional and consulting fees totaled $146,115 and $30,391 for the nine-month periods ended April 30, 2015 and 2014, respectively. Expenses in 2015 were significantly higher due to spending to bring the Company's tax and SEC filings current and stock based compensation totaling $44,902. The Company granted the CEO and VP Finance & CFO options to purchase an aggregate of 900,000 shares of the Company's common stock at an exercise price of $.05 per share, in exchange for unpaid services expenses.

Travel expenses totaled $3,251 and $601 were recorded during the nine-month periods ended April 30, 2015 and 2014, respectively. Travel activity has increased in 2015 in support of business needs and activity.

Insurance expenses totaled $9,600 and $-0- for the nine-month periods ended April 30, 2015 and 2014, respectively. The Company secured a Directors & Officers liability policy in 2015.

Other general and administrative expenses totaled $13,014 and $4,073 during the nine-month periods ended April 30, 2015 and 2014, respectively. The increase in 2015 is related to notification of an IRS penalty due to late filing of the 2010 tax return. This penalty has been contested.

We recorded interest expense of $48,754 and $145,810 for the nine-month periods ended April 30, 2015 and 2014, respectively. The interest costs were significantly higher in the 2014 period due to the Beneficial Conversion Feature amortization charge and charges incurred for the renewal and extension of certain promissory notes.

Our net loss was $220,734 and $180,875 for nine-month periods ended April 30, 2015 and 2014, respectively.

Liquidity and Capital

For the nine-month period ended April 30, 2015, $97,250 was provided by financing activities and $93,580 used in operating activities. In comparison, $42,000 was provided by financing activities and $36,888 used in operating activity for the comparable prior year period.

We had a deficiency in working capital of $591,787 at April 30, 2015, as compared to $452,605 at July 31, 2014. The increase was primarily as a result of the amortization of debt discount related to the beneficial conversion feature on assorted convertible promissory notes, accrued liabilities related to promissory note interest and expenses related to bring the Company's tax and SEC filings current.

Going Concern

Our significant operating losses raise substantial doubt about our ability to continue as a going concern. Historically, we have been able to raise additional funding sufficient to continue as a going concern. We have incurred recurring losses, incurred liabilities in excess of assets over the past year, and have an accumulated deficit

of $8,387,408. Based upon current operating levels, we will be required to obtain additional capital or reconfigure our operations in order to sustain our operations through July 31, 2015.

Off Balance Sheet Arrangements

We do not have any material off balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not required for smaller reporting companies.

Item 4.

Controls and Procedures

AsThe ~~required~~Company’s byprincipal executive ~~SEC~~officer ~~rules~~and principal financial officer, wewith the assistance of other members of the Company’s management, have evaluated the effectiveness of the design and operation of ~~our~~the Company’s disclosure controls and procedures at(as ~~the~~such ~~end~~term ofis ~~the~~defined ~~period~~in ~~covered~~Rules 13a-15(e) byand ~~this~~15d-15(e) ~~report. This~~under ~~evaluation~~the ~~was~~Exchange ~~carried~~Act) ~~out~~as ~~under~~of the ~~supervision~~end ~~and~~of ~~with~~ the ~~participation~~period ofcovered ~~our~~by ~~management,~~this ~~including~~quarterly ~~our~~report. Based upon such evaluation, the Company’s principal executive officer and principal financial officer~~. Based~~ ~~on this evaluation, these officers~~ have concluded that the ~~design~~Company’s ~~and operation of our~~ disclosure controls and procedures ~~were~~are not effective toas ~~ensure~~of ~~that~~the ~~all~~end ~~required~~of ~~information~~the isperiod ~~presented~~covered inby ~~our~~this quarterly report ~~in a timely manner~~.

~~Disclosure~~The ~~controls~~Company’s ~~and~~principal executive ~~procedures~~officer ~~are our controls~~ and ~~other~~principal ~~procedures~~financial ~~that~~officer ~~are~~have ~~designed~~also toconcluded ~~ensure~~ that ~~information~~there ~~required~~was tono bechange ~~disclosed by us~~ in the ~~reports~~Company’s ~~that~~internal wecontrol over ~~file~~financial orreporting ~~submit~~(as ~~under~~such ~~the~~term ~~Exchange Act~~ is ~~recorded,~~defined ~~processed,~~in ~~summarized~~Rule ~~and~~13a-15(f) ~~reported,~~under ~~within~~ the ~~time~~Exchange ~~periods~~Act) ~~specified~~that inoccurred during the ~~SEC's~~quarter ~~rules~~ended ~~and forms. Disclosure controls and procedures include~~October 31, ~~without~~2021 ~~limitation, controls and procedures designed to ensure~~ that ~~information~~has ~~required~~materially toaffected, beor ~~disclosed by us in the reports that we file under the Exchange Act~~ is ~~accumulated~~reasonably ~~and~~likely ~~communicated~~ to ~~our~~materially ~~management~~affect, ~~including~~the ~~principal~~Company’s ~~executive~~internal ~~officer~~control ~~and~~over ~~principal~~ financial ~~officer, as appropriate, to allow timely decisions regarding required disclosure~~ reporting.

During the fiscal quarter ended April 30, 2015, there were no other changes in our internal control over financial reporting or in other factors that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting, except as described above.11

20PART II. OTHER INFORMATION

~~Part~~Item II2. ~~OTHER~~ ~~INFORMATION~~Unregistered Sales of Equity Securities and Use of Proceeds.

~~Item~~Purchases ~~1. Legal~~of ~~Proceedings~~Equity Securities

~~None~~We did not, nor did any affiliated purchaser, make any repurchases of our securities during the three months ended October 31, 2021.

Item 1A. Risk Factors

Not required of smaller reporting companies.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

There were no issuances of Equity Securities during the period ending April 30, 2015.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

None.

21Item 6. Exhibits.

Item 6. Exhibits

Exhibit No.		Description
2.1		Notice of Entry of Order Appointing, Eight Judicial District Court, Clark County, Nevada, Case No.: A-19-791451-P dated May 7, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021). **
2.2		Notice of Entry of Order Discharging, Eight Judicial District Court, Clark County, Nevada, Case No.: A-19-791451-P dated October 16, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021). **
3.1		Amended and Restated Articles of Incorporation (Filed as an exhibit to Form SB-2, File No. 333-129398, on November 2, 2005). **
3.2		Amended Bylaws (Filed as an exhibit to Form SB-2, File No. 333-129398, on November 2, 2005). **
3.3		Certificate of Change Pursuant to NRS 78.209 effective July 31, 2007 (Filed as an exhibit to the Form 8-K dated July 31, 2007, filed August 6, 2007). **
3.4		Certificate of Designation Pursuant to NRS 78.1955 effective December 8, 2008 (Filed as an exhibit to Form 8-K dated December 8, 2008, filed December 10, 2008). **
3.5		Amendment to Certificate of Designation Pursuant to NRS 78.1955 effective December 15, 2008 (Filed as an exhibit to the Form 8-K dated December 15, 2008, filed December 17, 2008). **
3.6		Certificate of Reinstatement dated July 10, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021). **
3.7		Certificate of Designation dated July 10, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021). **
3.8		Certificate of Amendment by Custodian filed July 10, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021). **
3.9		Certificate of Amendment Filed July 10, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021). **
3.11		Certificate of Amendment to the Articles of Incorporation Filed May 26, 2021 (Filed as an exhibit to Form 10-12G on June 21, 2021). **
10		Intellectual Property License Agreement Between Worldwide Strategies Incorporated and Dr. Sandra Kaufmann (Filed as an exhibit to Form 10-12G on June 21, 2021) **
10.1		2005 Stock Plan (Filed as an exhibit to the initial filing of the registration statement on Form SB-2, File No. 333-129398, on November 2, 2005). **
24.1		Power of Attorney
31.1	*	Certification of principal executive officer of the Company, pursuant to Securities Exchange Act Rule 13a-14(a)
31.2	*	Certification of principal financial officer of the Company, pursuant to Securities Exchange Act Rule 13a-14(a)
32.1	*	Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, signed by the principal executive officer of the Company and the principal financial officer of the Company
101.INS	**	XBRL Instance Document
101.SCH	**	XBRL Taxonomy Extension Schema Document
101.CAL	**	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	**	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	**	XBRL Extension Labels Linkbase Document
101.PRE	**	XBRL Taxonomy Extension Presentation Linkbase Document

Regulation S-K Number	Exhibit
2.1	Share Exchange Agreement by and between Worldwide Strategies Incorporated, Centric Rx, Inc., Jim Crelia, Jeff Crelia, J. Jireh, Inc. and Canada Pharmacy Express, Ltd. dated as of June 28, 2007 (1)
3.1	Amended and Restated Articles of Incorporation (2)
3.2	Amended Bylaws (2)
3.3	Articles of Exchange Pursuant to NRS 92A.200 effective July 31, 2007 (3)
3.4	Certificate of Change Pursuant to NRS 78.209 effective July 31, 2007 (3)
3.5	Certificate of Designation Pursuant to NRS 78.1955 effective December 8, 2008 (4)
3.6	Amendment to Certificate of Designation Pursuant to NRS 78.1955 effective December 15, 2008 (5)
10.1	2005 Stock Plan (2)
10.2	Acknowledgement of Debt Satisfaction and Full Release with James P.R. Samuels dated as of July 31, 2013 (6)
10.3	Acknowledgement of Debt Satisfaction and Full Release with W. Earl Somerville dated as of July 31, 2013 (6)
31.1	Rule 13a-14(a) Certification of James P.R. Samuels
31.2	Rule 13a-14(a) Certification of Thomas E. McCabe
32.1	Certification of James P.R. Samuels Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002
32.2	Certification of Thomas E. McCabe Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002
101	Interactive Data Files

*Filed herewith

~~______________________________________________________________~~ **Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Act of 1934 and otherwise are not subject to liability.

~~(1) Filed as an exhibit to the Current Report on Form 8-K dated June 28, 2007, filed July 2, 2007.~~12

(2) Filed as an exhibit to the initial filing of the registration statement on Form SB-2, File No. 333-129398, on November 2, 2005.

(3) Filed as an exhibit to the Current Report on Form 8-K dated July 31, 2007, filed August 6, 2007.

(4) Filed as an exhibit to the Current Report on Form 8-K dated December 8, 2008, filed December 10, 2008.

(5) Filed as an exhibit to the Current Report on Form 8-K dated December 15, 2008, filed December 17, 2008.

(6) Filed as an exhibit to the Annual Report on Form 10-K for the fiscal year ended July 31, 2014, filed February 17, 2015.

*In accordance with Rule 406T of Regulation S-T, the information in these exhibits shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	WORLDWIDE STRATEGIES INCORPORATED
	WORLDWIDE STRATEGIES, INC.
Date: 8 June 2015	By:	/s/ James P.R. Samuels
Date: December 14, 2021	By:	/s/ ADAM LAUFER
		James P.R. Samuels
		Name:	Adam Laufer
		Chief Executive Officer
		Title:	Chief Executive Officer (Principal Executive Officer)
		(Principal Executive Officer)
Date: 8 June 2015	By:	/s/ Thomas E. McCabe
		Thomas E. McCabe
		Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)

Date: December 14, 2021

By:

/s/ PAVAN CHARAN

Name:

Pavan Charan

Title:

Chief Financial Officer and Principal
Accounting Officer

(Principal Financial Officer)

Filing Compare · WORLDWIDE STRATEGIES INC